| Literature DB >> 31604686 |
Antonia Wallrapp1, Patrick R Burkett2, Samantha J Riesenfeld3, Se-Jin Kim2, Elena Christian4, Raja-Elie E Abdulnour5, Pratiksha I Thakore3, Alexandra Schnell1, Conner Lambden4, Rebecca H Herbst3, Pavana Khan5, Kazutake Tsujikawa6, Ramnik J Xavier7, Isaac M Chiu8, Bruce D Levy5, Aviv Regev9, Vijay K Kuchroo10.
Abstract
Neuroimmune interactions have emerged as critical modulators of allergic inflammation, and type 2 innate lymphoid cells (ILC2s) are an important cell type for mediating these interactions. Here, we show that ILC2s expressed both the neuropeptide calcitonin gene-related peptide (CGRP) and its receptor. CGRP potently inhibited alarmin-driven type 2 cytokine production and proliferation by lung ILC2s both in vitro and in vivo. CGRP induced marked changes in ILC2 expression programs in vivo and in vitro, attenuating alarmin-driven proliferative and effector responses. A distinct subset of ILCs scored highly for a CGRP-specific gene signature after in vivo alarmin stimulation, suggesting CGRP regulated this response. Finally, we observed increased ILC2 proliferation and type 2 cytokine production as well as exaggerated responses to alarmins in mice lacking the CGRP receptor. Together, these data indicate that endogenous CGRP is a critical negative regulator of ILC2 responses in vivo.Entities:
Keywords: CGRP; Ramp1; airway inflammation; allergic inflammation; neuro-immune interaction; neuropeptides; type 2 innate lymphoid cells
Mesh:
Substances:
Year: 2019 PMID: 31604686 PMCID: PMC7076585 DOI: 10.1016/j.immuni.2019.09.005
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745